Bandingkan Harga & Kinerja Indo Komoditi Korpora Tbk. (INCF) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Indo Komoditi Korpora Tbk. dan Organon Pharma Indonesia Tbk.: Indo Komoditi Korpora Tbk. diperdagangkan di Rp50 (kapitalisasi pasar 71,92 M), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Organon Pharma Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| INCF | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 71,92 M | 104,4 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Indo Komoditi Korpora Tbk.
PT Indo Komoditi Korpora Tbk (the Company) and its subsidiary (together referred as the "Group"), established in the Republic of Indonesia based on deed of establishment No. 125 dated February 23rd, 1982, made in the presence of Frederik Alexander Tumbuan, S.H., Notary in Jakarta, which the Company was originally named PT Indo Alaya Leasing Corporation.
Selengkapnya di halaman INCF →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
